Brege Laura bought PCRX
June 10, 2026 · Form 4 insider transaction
Brege Laura bought 6,405 shares of Pacira BioSciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,405
Price
$0.00
Total value
N/A
InsiderBrege Laura
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 10, 2026
Filing dateJune 12, 2026
Shares owned after30,120
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.